ArticleMetabolism: clinical and experimental2020
Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.
Article in Metabolism: clinical and experimental, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Association of body mass index (BMI) with critical COVID-19 and in-hospital mortality: A dose-response meta-analysis.Metabolism: clinical and experimental · 2021Pooled it
- Obesity in patients with COVID-19: a systematic review and meta-analysis.Metabolism: clinical and experimental · 2020Pooled it
- Body Mass Index and Prognosis of COVID-19 Infection. A Systematic Review.Frontiers in endocrinology · 2020Pooled it
- COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes.Frontiers in immunology · 2022Review
- An overview of SARS-COV-2-related hepatic injury.Hepatology forum · 2021Review
- Liver injury in the era of COVID-19.World journal of gastroenterology · 2021Review
- Viral Clearance Course of COVID-19 Outbreaks.Journal of multidisciplinary healthcare · 2021Article
- Obesity is a potential risk factor contributing to clinical manifestations of COVID-19.International journal of obesity (2005) · 2020Article
- Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD).Metabolism: clinical and experimental · 2020Article
- Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study.The FEBS journal · 2020Article
- Proper Management of People with Obesity during the COVID-19 Pandemic.Journal of obesity & metabolic syndrome · 2020Article
Corrections and comments
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.